Bruce Bernstein
CIK 1665472 · last filed 2026-10-09
Bruce Bernstein is a corporate insider who has filed 86 SEC Form 4 insider transactions across 11 companies since 2016. The most recent filing, for WRAP, was dated Oct 9, 2026. Across all open-market trades the lifetime net is +$445.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $903.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
XSPA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10017
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WRAP | Director | 272,002 | $1.25 | $340.0K | $0 | 21 | 2026-10-09 |
| XWEL | Director | 839,882 | $0.56 | $470.6K | $21.1K | 7 | 2026-09-02 |
| TAOX | Director | 30,897 | $2.72 | $84.0K | $0 | 4 | 2026-05-19 |
| RREVU | Director | — | $9.99 | — | $0 | 1 | 2026-05-05 |
| QCLS | Director | 25,000 | $0.37 | $9.2K | $0 | 2 | 2026-04-15 |
| TAO Synergies Inc. (SNPX) Delisted | Director | 1,103 | $24.55 | $27.1K | -$26.4K | 9 | 2025-04-07 |
| Petros Pharmaceuticals, Inc. (PTPI) Delisted | Director | 12,334 | $0.01 | $76 | $0 | 8 | 2025-02-21 |
| XWELL, Inc. (XSPA) Delisted | Director | 729,198 | $0.66 | $477.6K | $332.7K | 13 | 2022-03-21 |
| NTRP | Director | 0 | $1.15 | $0 | $0 | 6 | 2020-12-03 |
| XWELL, Inc. (FH) Delisted | Director | 788,290 | — | — | $117.6K | 8 | 2017-08-21 |
| XWELL, Inc. (VRNG) Delisted | Director | — | — | — | $0 | 1 | 2016-04-06 |
Recent Filings
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-09 | WRAP | Grant (A) | +21,154 | $0 | EDGAR |
| 2026-09-02 | XWEL | Grant (A) | +500,000 | $0 | EDGAR |
| 2026-07-06 | WRAP | Grant (A) | — | $0 | EDGAR |
| 2026-06-05 | — | Grant (A) | +1,875,000 | $0 | |
| 2026-05-19 | TAOX | Grant (A) | — | $0 | EDGAR |
| 2026-05-05 | RREVU | Grant (A) | — | $0 | EDGAR |
| 2026-05-01 | WRAP | Grant (A) | +19,643 | $0 | EDGAR |
| 2026-04-15 | QCLS | Grant (A) | — | $0 | EDGAR |
| 2026-04-08 | TAOX | Grant (A) | — | $0 | EDGAR |
| 2026-03-02 | XWEL | Grant (A) | +100,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.